Claims
- 1. A method for inhibiting the toxicity of Bacillus anthracis, which comprises the steps of introducing at least one type of DNA-encoding single-chain Fv fragment (scFv) protein into host mammalian cells, whereby the host mammalian cells produce an immunoglobulin that functions in an immune response against protective antigen PA83 of Bacillus anthracis.
- 2. The method as described in claim 9, wherein the scFv protein is selected from the group consisting of scFv #1 protein, scFv #4 protein, and mixtures thereof.
- 3. The method as described in claim 9, wherein the host mammalian cells comprise human epithelial cells.
STATEMENT REGARDING RELATED APPLICATIONS
[0001] This application is a continuation-in-part of patent application Ser. No. 09/992,742 filed Nov. 16, 2001, which is a divisional of patent application Ser. No. 09/273,839 filed Mar. 22,1999, all incorporated by reference herein.
STATEMENT REGARDING FEDERAL RIGHTS
[0002] This invention was made with government support under Contract No. W-7405-ENG-36 awarded by the U.S. Department of Energy to The Regents of The University of California. The government has certain rights in the invention.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09273839 |
Mar 1999 |
US |
Child |
09992742 |
Nov 2001 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09992742 |
Nov 2001 |
US |
Child |
10375356 |
Feb 2003 |
US |